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Aims  
Large bone defects due to tumor resection and trauma require extensive surgical therapy. 
The “gold standard” to treat these large defects is the use of autologous bone grafts (1). 
Autologous bone chips are harvested from the iliac crest and transplanted into the defect. 
The drawbacks in using this include the limitation of autologous bone available, donor site 
morbidity as well as the risk for incomplete graft integration and graft resorption when the 
defect exceeds more than 5 cm. This has led to the development of novel methods based on 
Tissue Engineering (TE).  
One of the promising bone TE approaches is the use of osteo/chondro-progenitor cells in 
combination with 3D open porous biomaterials, i.e. 3D scaffolds (2). In a study of Roberts et 
al. (2) and Perka et al. (3), the bone forming capacity of periosteum-derived cells (PDCs) are 
identified as potential cell source for bone TE. Human PDCs (hPDCs) were seeded onto a 
3D scaffold composed of calcium phosphate (CaP) particles in an open collagen network and 
evaluated for their capacity to form bone in an in vivo ectopic mouse model as a first line 
screening model for their quality assessment. To enable a fast, reliable and quantitative 
assessment, the explanted cell-scaffold combinations are evaluated using microfocus X-ray 
computed tomography, i.e. microCT (4) to visualize and quantify the newly formed bone 
volume, and provide real 3D information. In the study of Roberts et al (2), it was shown that 
the volume of newly formed bone analyzed by microCT corresponds well to the 
histomorphometric results, still used as ‘gold standard’ for evaluating the bone forming 
capacity of cell/scaffold combinations.  As an additional benefit of micro-CT, the information 
gathered from the 3D image analysis can be produced within one day instead of at least 3 
weeks when using histology and histomorphometric 2D analysis.  
The aim of this study was twofold: to use micro-CT as a quality assay to (i) evaluate whether 
NuOss™ can be used to direct bone formation of any progenitor population by testing the 
best performing CaP scaffold from the study of Roberts et al. (2), namely NuOss™, with 
other alternative progenitor populations than the hPDCs (i.e. cell type-specific variability) 
and (ii) screen different individual hPDCs by seeding them onto NuOss™ to evaluate the 
donor-specific variability.  
 
Materials and methods 
To assess the cell type-specific variability, two different alternative progenitor populations 
were used in comparison with hPDCs (coming from 3 individual donors), namely (i) human 
synovium derived cells (hSDCs) from 3 individual donors and (ii) human mesoangioblasts 
(hMES) from 2 individual donors. All cells were screened in the in-house standard ectopic 
nude mouse assay and evaluated by microCT to evaluate their direct bone formation on 
NuOss™. To evaluate the patient-specific variability, the bone forming capacity of 15 
individual hPDC donors seeded onto NuOss™ was quantified and compared. 
For all experiments, one million of cells were seeded onto a 21 mm³ cylindrical 3D scaffold. 
Allowing cell attachment, the cell-scaffold combinations were incubated overnight at 37°C. 
The next day, the constructs were implanted in duplicate subcutaneously in the back of 
NMRI-nu/nu mice. After 8 weeks, the constructs were explanted and immediately fixed in 4% 
paraformaldehyde, and scanned using high-resolution micro-CT on a Skyscan 1172 system 
[Skyscan NV, Kontich, Belgium] at an isotropic voxel size  of (4.5 µm)³. Since each construct 
had a similar composition, for all explants a source voltage and current of 60kV and 167 µA 
respectively and a filter of 0.5mm Al were applied. Using a rotation step of 0.3° over a total of 
180° resulted in 640 radiographic images. After reconstruction using dedicated software 
[NRecon, Skyscan NV, Kontich, Belgium], a total of about 900 greyscale axial micro-CT 
images per sample were generated.  Manual, but consistent global segmentation of the 
newly formed mineralized tissues from the CaP particles present in the explants was carried 
out based on the greyscale histogram to allow quantification of parameters such as the 
volume fraction of newly formed bone within the available scaffold volume using CTAn 
[Skyscan NV, Kontich, Belgium]. 
 
Results 
-  Cell type-specific variability 
MicroCT image analysis of the explants revealed between the different cell types (fig. 1). For 
both the hMESs and the hSDCs, a limited amount of bone (on average 6.10 % and 7.45 % 
respectively) and only small bone fragments lying adjacent to the CaP particles were 
observed. The hPDCs resulted in a larger amount of newly formed bone (on average 12.68 
%) compared to the hMESs and the hSDCs. This showed that (i) hPDCs perform well in 
NuOss™, as was also shown in Roberts et al. (2) and (ii) the bone forming capacity of a 
specific 3D scaffold is highly cell type-dependent. Thus, in order to optimize the scaffold 
design and characteristics, one always needs to evaluate the cell/scaffold combination rather 
than only focusing on one of both. 
A large standard deviation on the results of the hPDCs can be noticed in fig. 1. This implies 
that, even within the same cell type, a large variability in bone forming capacity can be 
present.  
 
- Donor-specific variability 
MicroCT images of the explants of the different hPDCs donors revealed, for each individual 
donor, bone spicules in between the CaP particles or in close relation to these particles 
(fig.3). However, quantification of the volume fraction of the newly formed bone in the 
available scaffold volume revealed a large spread between the individual donors, which 
shows the importance of individual donor screening as it influences donor selection in 
function of the release criteria (fig.2). Within the screened hPDCs a group of donors 
expressed a bone forming capacity above the 10 % threshold that showed a significantly 
higher percentage of newly formed bone (up to 13.99 % on average) (fig.3A), compared to 
another group of donors that only expressed a limited amount of newly formed bone 
(average of 8.61 %) which is below the 10 % threshold (fig.3B).  
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